Impact of New Hormonotherapy Drugs in Prostatic Cancer on the Risk of Cardiovascular Events : a Pharmacoepidemiology Study Using the French Health Care Claims Database
CompletedOBSERVATIONAL
Enrollment
52,000
Participants
Timeline
Start Date
January 7, 2025
Primary Completion Date
June 30, 2025
Study Completion Date
June 30, 2025
Conditions
Prostate Cancer
Trial Locations (1)
14000
CHU Caen, Caen
All Listed Sponsors
lead
University Hospital, Caen
OTHER
NCT06902441 - Impact of New Hormonotherapy Drugs in Prostatic Cancer on the Risk of Cardiovascular Events : a Pharmacoepidemiology Study Using the French Health Care Claims Database | Biotech Hunter | Biotech Hunter